99 related articles for article (PubMed ID: 17703704)
1. Drug utilization still growing, though price increases moderate for common nonspecialty drugs.
Capitation Rates Data; 2007 Aug; 12(8):94-6. PubMed ID: 17703704
[No Abstract] [Full Text] [Related]
2. Drug trend slows in 2003, but higher utilization still driving costs.
Capitation Rates Data; 2004 Jul; 9(7):78-82. PubMed ID: 15341340
[No Abstract] [Full Text] [Related]
3. Drugs still influence health costs, but trend abating.
Capitation Rates Data; 2003 Oct; 8(10):114-20. PubMed ID: 14621548
[No Abstract] [Full Text] [Related]
4. Rising drug costs prompt new uses for old pills.
Opar A
Nat Med; 2006 Dec; 12(12):1333. PubMed ID: 17151672
[No Abstract] [Full Text] [Related]
5. Defying the prescription. Forget forecasts--drug sales soar under managed care.
Hensley S
Mod Healthc; 1998 Apr; 28(15):42. PubMed ID: 10178321
[No Abstract] [Full Text] [Related]
6. Dissecting drug cost trends.
Navarro RP
Med Interface; 1997 Jul; 10(7):80-2. PubMed ID: 10173118
[No Abstract] [Full Text] [Related]
7. Stats & facts. Pharmaceutical utilization contributes to the rise in pharmacy costs.
Manag Care Interface; 2000 Dec; 13(12):52-3. PubMed ID: 11147547
[No Abstract] [Full Text] [Related]
8. Generics lead moderating drug trend, but price spike looms.
Capitation Rates Data; 2006 Jul; 11(7):73-80. PubMed ID: 16944664
[No Abstract] [Full Text] [Related]
9. [Increasing drug costs. The society's drug expenditures are strongly increasing. If this trend continues we have to make other priorities].
Andreasen J
Ugeskr Laeger; 2003 Jul; 165(29):2873-6. PubMed ID: 12908355
[No Abstract] [Full Text] [Related]
10. Utilization, price, and spending trends for antidepressants in the US Medicaid Program.
Chen Y; Kelton CM; Jing Y; Guo JJ; Li X; Patel NC
Res Social Adm Pharm; 2008 Sep; 4(3):244-57. PubMed ID: 18794035
[TBL] [Abstract][Full Text] [Related]
11. Principal components analysis of drug expenditure and utilisation trends for major therapeutic classes in US Medicaid programmes.
Guo JJ; Jing Y; Nguyen K; Fan H; Li X; Kelton CM
J Med Econ; 2008; 11(4):671-94. PubMed ID: 19450075
[TBL] [Abstract][Full Text] [Related]
12. Soaring price of cancer drugs leads plans to new approaches.
Sipkoff M
Manag Care; 2007 Aug; 16(8):12-3. PubMed ID: 17886533
[No Abstract] [Full Text] [Related]
13. Assessing the value equation can help guide drug usage.
Capitation Rates Data; 2000 May; 5(5):53-5. PubMed ID: 11066971
[No Abstract] [Full Text] [Related]
14. Where are we going with drugs to treat MS? Will cost continue to increase?
Oger J; AlKhawajah M
Can J Neurol Sci; 2010 May; 37(3):305-8. PubMed ID: 20481262
[No Abstract] [Full Text] [Related]
15. Drug costs finally slowing, but noncompliance still an issue.
Capitation Rates Data; 2005 Jun; 10(6):66-72. PubMed ID: 16124558
[No Abstract] [Full Text] [Related]
16. Inflation. Price hikes on AIDS drug not protected by antitrust laws.
AIDS Policy Law; 2005 Sep; 20(18):6. PubMed ID: 16208823
[No Abstract] [Full Text] [Related]
17. [Danish drug consumption trends].
Madsen HK; Hallas J
Ugeskr Laeger; 2009 Mar; 171(10):775-7. PubMed ID: 19265597
[TBL] [Abstract][Full Text] [Related]
18. Biggest increases in specialty drug costs seen in rheumatologic, cancer, and hemophilia agents.
Manag Care; 2005 Feb; 14(2):68. PubMed ID: 15782849
[No Abstract] [Full Text] [Related]
19. I.V. solution prices are holding steady; little price change, up or down, expected.
Hosp Mater Manage; 1996 Jun; 21(6):1, 10-1. PubMed ID: 10158078
[No Abstract] [Full Text] [Related]
20. Make patients aware of discounted prescription drugs.
Ivey D
Mich Med; 2009; 108(3):21. PubMed ID: 19489358
[No Abstract] [Full Text] [Related]
[Next] [New Search]
